{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T22:32:54Z","timestamp":1789165974203,"version":"build-2803163510"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2026,3,9]],"date-time":"2026-03-09T00:00:00Z","timestamp":1773014400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,3,9]],"date-time":"2026-03-09T00:00:00Z","timestamp":1773014400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100009619","name":"AMED","doi-asserted-by":"crossref","award":["256f0137009j0001"],"award-info":[{"award-number":["256f0137009j0001"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100009619","name":"AMED","doi-asserted-by":"crossref","award":["JP24ama121018"],"award-info":[{"award-number":["JP24ama121018"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"crossref"}]},{"name":"JSPS KAKENHI","award":["24K02574"],"award-info":[{"award-number":["24K02574"]}]},{"name":"JSPS KAKENHI","award":["25K12471"],"award-info":[{"award-number":["25K12471"]}]},{"name":"JSPS KAKENHI","award":["25K18360"],"award-info":[{"award-number":["25K18360"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Human Cell"],"DOI":"10.1007\/s13577-026-01363-7","type":"journal-article","created":{"date-parts":[[2026,3,9]],"date-time":"2026-03-09T13:34:31Z","timestamp":1773063271000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Establishment and characterization of NCC-GCTB16-C1: novel patient-derived cell line of giant cell tumor of bone"],"prefix":"10.1007","volume":"39","author":[{"given":"Kenta","family":"Kono","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yomogi","family":"Shiota","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia","family":"Osaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ting-Ting","family":"Shu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satoshi","family":"Kamio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shintaro","family":"Iwata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shogo","family":"Nishino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akihiko","family":"Yoshida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sumio","family":"Ohtsuki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seiji","family":"Ohtori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akira","family":"Kawai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6405-7792","authenticated-orcid":false,"given":"Tadashi","family":"Kondo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,9]]},"reference":[{"key":"1363_CR1","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1634\/theoncologist.2013-0432","volume":"19","author":"L van der Heijden","year":"2014","unstructured":"van der Heijden L, Dijkstra PD, van de Sande MA, et al. The clinical approach toward giant cell tumor of bone. Oncologist. 2014;19:550\u201361.","journal-title":"Oncologist"},{"key":"1363_CR2","first-page":"197","volume":"33","author":"CFD Chakarun","year":"2013","unstructured":"Chakarun CFD, Gottsegen C, Patel D, White E, Matcuk G. Giant cell tumor of bone: review, mimics, and new developments in treatment. Musculoskelet Imaging. 2013;33:197\u2013211.","journal-title":"Musculoskelet Imaging"},{"key":"1363_CR3","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1051\/sicotj\/2017041","volume":"3","author":"AF Mavrogenis","year":"2017","unstructured":"Mavrogenis AF, Igoumenou VG, Megaloikonomos PD, Panagopoulos GN, Papagelopoulos PJ, Soucacos PN. Giant cell tumor of bone revisited. SICOT J. 2017;3:54.","journal-title":"SICOT J"},{"key":"1363_CR4","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1007\/s11999-010-1501-7","volume":"469","author":"FM Klenke","year":"2011","unstructured":"Klenke FM, Wenger DE, Inwards CY, Rose PS, Sim FH. Giant cell tumor of bone: risk factors for recurrence. Clin Orthop Relat Res. 2011;469:591\u20139.","journal-title":"Clin Orthop Relat Res"},{"key":"1363_CR5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ctrv.2009.09.002","volume":"36","author":"C Errani","year":"2010","unstructured":"Errani C, Ruggieri P, Asenzio MA, et al. Giant cell tumor of the extremity: A review of 349 cases from a single institution. Cancer Treat Rev. 2010;36:1\u20137.","journal-title":"Cancer Treat Rev"},{"key":"1363_CR6","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1111\/his.14265","volume":"78","author":"WJ Anderson","year":"2021","unstructured":"Anderson WJ, Doyle LA. Updates from the 2020 World Health Organization classification of soft tissue and bone tumours. Histopathology. 2021;78:644\u201357.","journal-title":"Histopathology"},{"key":"1363_CR7","doi-asserted-by":"publisher","first-page":"1576","DOI":"10.1097\/PAS.0000000000000512","volume":"39","author":"AHS Cleven","year":"2015","unstructured":"Cleven AHS, Briaire-de Bruijn I, Szuhai K, Cleton-Jansen A, Bove\u00b4e J. Mutation analysis of H3F3A and H3F3B as a diagnostic tool for giant cell tumor of bone and chondroblastoma. Am J Surg Pathol. 2015;39:1576\u201383.","journal-title":"Am J Surg Pathol"},{"key":"1363_CR8","doi-asserted-by":"publisher","first-page":"1479","DOI":"10.1038\/ng.2814","volume":"45","author":"S Behjati","year":"2013","unstructured":"Behjati S, Tarpey PS, Presneau N, et al. Distinct H3F3A and H3F3B driver mutations define chondroblastoma and giant cell tumor of bone. Nat Genet. 2013;45:1479\u201382.","journal-title":"Nat Genet"},{"key":"1363_CR9","doi-asserted-by":"publisher","first-page":"914","DOI":"10.1111\/his.13448","volume":"72","author":"I Kato","year":"2018","unstructured":"Kato I, Furuya M, Matsuo K, Kawabata Y, Tanaka R, Ohashi K. Giant cell tumours of bone treated with denosumab: histological, immunohistochemical and H3F3A mutation analyses. Histopathology. 2018;72:914\u201322.","journal-title":"Histopathology"},{"key":"1363_CR10","doi-asserted-by":"publisher","DOI":"10.3390\/cancers13205119","author":"RG Forsyth","year":"2021","unstructured":"Forsyth RG, Krenacs T, Athanasou N, Hogendoorn PCW. Cell biology of giant cell tumour of bone: crosstalk between m\/wt nucleosome H3.3, telomeres and osteoclastogenesis. Cancers (Basel). 2021. https:\/\/doi.org\/10.3390\/cancers13205119.","journal-title":"Cancers (Basel)"},{"key":"1363_CR11","doi-asserted-by":"publisher","first-page":"1321","DOI":"10.1007\/s13577-020-00415-w","volume":"33","author":"R Noguchi","year":"2020","unstructured":"Noguchi R, Yoshimatsu Y, Ono T, et al. Establishment and characterization of NCC-GCTB1-C1: a novel patient-derived cancer cell line of giant cell tumor of bone. Hum Cell. 2020;33:1321\u20138.","journal-title":"Hum Cell"},{"key":"1363_CR12","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1007\/s13577-021-00639-4","volume":"35","author":"T Ono","year":"2022","unstructured":"Ono T, Noguchi R, Yoshimatsu Y, et al. Establishment and characterization of the NCC-GCTB4-C1 cell line: a novel patient-derived cell line from giant cell tumor of bone. Hum Cell. 2022;35:392\u20139.","journal-title":"Hum Cell"},{"key":"1363_CR13","doi-asserted-by":"publisher","first-page":"1621","DOI":"10.1007\/s13577-022-00724-2","volume":"35","author":"T Akiyama","year":"2022","unstructured":"Akiyama T, Yoshimatsu Y, Noguchi R, et al. Establishment and characterization of NCC-GCTB5-C1: A novel cell line of giant cell tumor of bone. Hum Cell. 2022;35:1621\u20139.","journal-title":"Hum Cell"},{"key":"1363_CR14","doi-asserted-by":"publisher","DOI":"10.1007\/s13577-025-01254-3","volume":"38","author":"Y Adachi","year":"2025","unstructured":"Adachi Y, Ono T, Noguchi R, et al. Establishment and characterization of two novel patient-derived cell lines from giant cell tumor of bone: NCC-GCTB11-C1 and NCC-GCTB12-C1. Hum Cell. 2025;38:128.","journal-title":"Hum Cell"},{"key":"1363_CR15","doi-asserted-by":"publisher","DOI":"10.1007\/s13577-024-01150-2","volume":"38","author":"S Iwata","year":"2024","unstructured":"Iwata S, Ono T, Noguchi R, et al. Establishment and characterization of NCC-GCTB14-C1 and NCC-GCTB15-C1: Two novel patient-derived cell lines of giant cell tumor of bone. Hum Cell. 2024;38:20.","journal-title":"Hum Cell"},{"key":"1363_CR16","doi-asserted-by":"publisher","first-page":"25","DOI":"10.7171\/jbt.18-2902-002","volume":"29","author":"A Bairoch","year":"2018","unstructured":"Bairoch A. The Cellosaurus, a cell-line knowledge resource. J Biomol Tech. 2018;29:25\u201338.","journal-title":"J Biomol Tech"},{"key":"1363_CR17","doi-asserted-by":"publisher","first-page":"953","DOI":"10.1111\/cas.14669","volume":"112","author":"T Kondo","year":"2021","unstructured":"Kondo T. Current status and future outlook for patient-derived cancer models from a rare cancer research perspective. Cancer Sci. 2021;112:953\u201361.","journal-title":"Cancer Sci"},{"key":"1363_CR18","first-page":"1142","volume":"14","author":"J Dinic","year":"2024","unstructured":"Dinic J, JovanovicStojanov S, Dragoj M, Grozdanic M, Podolski-Renic A, Pesic M. Cancer patient-derived cell-based models: applications and challenges in functional precision medicine. Life (Basel). 2024;14:1142.","journal-title":"Life (Basel)"},{"key":"1363_CR19","first-page":"2","volume":"4","author":"A Sobti","year":"2016","unstructured":"Sobti A, Agrawal P, Agarwala S, M. A. Giant cell tumor of bone - an overview. Arch Bone Jt Surg. 2016;4:2\u20139.","journal-title":"Arch Bone Jt Surg"},{"key":"1363_CR20","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1002\/gcc.22469","volume":"56","author":"K Ogura","year":"2017","unstructured":"Ogura K, Hosoda F, Nakamura H, et al. Highly recurrent H3F3A mutations with additional epigenetic regulator alterations in giant cell tumor of bone. Genes Chromosomes Cancer. 2017;56:711\u20138.","journal-title":"Genes Chromosomes Cancer"},{"key":"1363_CR21","doi-asserted-by":"publisher","first-page":"27354","DOI":"10.1073\/pnas.2006076117","volume":"117","author":"SU Jain","year":"2020","unstructured":"Jain SU, Khazaei S, Marchione DM, et al. Histone H3.3 G34 mutations promote aberrant PRC2 activity and drive tumor progression. Proc Natl Acad Sci U S A. 2020;117:27354\u201364.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1363_CR22","doi-asserted-by":"publisher","first-page":"8012","DOI":"10.1073\/pnas.121616198","volume":"98","author":"JR Masters","year":"2001","unstructured":"Masters JR, Thomson JA, Daly-Burns B, et al. Short tandem repeat profiling provides an international reference standard for human cell lines. Proc Natl Acad Sci U S A. 2001;98:8012\u20137.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1363_CR23","first-page":"329","volume":"18","author":"H Tanabe","year":"1999","unstructured":"Tanabe H, Takada Y, Minegishi D, Kurematsu M, Masui T, Mizusawa H. Cell line individualization by STR multiplex system in the cell bank found cross-contamination between ECV304 and EJ-1\/T24. Tiss Cult Res Commun. 1999;18:329\u201338.","journal-title":"Tiss Cult Res Commun"},{"key":"1363_CR24","doi-asserted-by":"publisher","first-page":"2510","DOI":"10.1002\/ijc.27931","volume":"132","author":"A Capes-Davis","year":"2013","unstructured":"Capes-Davis A, Reid YA, Kline MC, et al. Match criteria for human cell line authentication: Where do we draw the line? Int J Cancer. 2013;132:2510\u20139.","journal-title":"Int J Cancer"},{"key":"1363_CR25","doi-asserted-by":"publisher","first-page":"1968","DOI":"10.1158\/2159-8290.CD-20-0461","volume":"10","author":"S Khazaei","year":"2020","unstructured":"Khazaei S, De Jay N, Deshmukh S, et al. H3.3 G34W promotes growth and impedes differentiation of osteoblast-like mesenchymal progenitors in giant cell tumor of bone. Cancer Discov. 2020;10:1968\u201387.","journal-title":"Cancer Discov"},{"key":"1363_CR26","doi-asserted-by":"publisher","first-page":"1082","DOI":"10.1053\/j.gastro.2017.06.008","volume":"153","author":"J Wang","year":"2017","unstructured":"Wang J, Mouradov D, Wang X, et al. Colorectal cancer cell line proteomes are representative of primary tumors and predict drug sensitivity. Gastroenterology. 2017;153:1082\u201395.","journal-title":"Gastroenterology"},{"key":"1363_CR27","doi-asserted-by":"publisher","DOI":"10.1016\/j.crmeth.2021.100039","volume":"1","author":"R Sinha","year":"2021","unstructured":"Sinha R, Luna A, Schultz N, Sander C. A pan-cancer survey of cell line tumor similarity by feature-weighted molecular profiles. Cell Rep Methods. 2021;1:100039.","journal-title":"Cell Rep Methods"},{"key":"1363_CR28","doi-asserted-by":"publisher","DOI":"10.1186\/s12864-016-2911-z","author":"G Jiang","year":"2016","unstructured":"Jiang G, Zhang S, Yazdanparast A, et al. Comprehensive comparison of molecular portraits between cell lines and tumors in breast cancer. BMC Genomics. 2016. https:\/\/doi.org\/10.1186\/s12864-016-2911-z.","journal-title":"BMC Genomics"},{"key":"1363_CR29","doi-asserted-by":"publisher","first-page":"1978","DOI":"10.7150\/jca.50897","volume":"12","author":"L Fang","year":"2021","unstructured":"Fang L, Liu YJ, Zhang YW, et al. Comparison of proteomics profiles between xenografts derived from cell lines and primary tumors of thyroid carcinoma. J Cancer. 2021;12:1978\u201389.","journal-title":"J Cancer"},{"key":"1363_CR30","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1093\/jnci\/djt007","volume":"105","author":"JP Gillet","year":"2013","unstructured":"Gillet JP, Varma S, Gottesman MM. The clinical relevance of cancer cell lines. J Natl Cancer Inst. 2013;105:452\u20138.","journal-title":"J Natl Cancer Inst"},{"key":"1363_CR31","doi-asserted-by":"publisher","DOI":"10.1186\/1476-4598-5-55","volume":"5","author":"A Ertel","year":"2006","unstructured":"Ertel A, Verghese A, Byers SW, Ochs M, Tozeren A. Pathway-specific differences between tumor cell lines and normal and tumor tissue cells. Mol Cancer. 2006;5:55.","journal-title":"Mol Cancer"},{"key":"1363_CR32","doi-asserted-by":"publisher","first-page":"581","DOI":"10.37349\/etat.2024.00237","volume":"5","author":"VV Pipiya","year":"2024","unstructured":"Pipiya VV, Gilazieva ZE, Issa SS, Rizvanov AA, Solovyeva VV. Comparison of primary and passaged tumor cell cultures and their application in personalized medicine. Explor Target Antitumor Ther. 2024;5:581\u201399.","journal-title":"Explor Target Antitumor Ther"}],"container-title":["Human Cell"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13577-026-01363-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13577-026-01363-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13577-026-01363-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,9]],"date-time":"2026-03-09T13:34:33Z","timestamp":1773063273000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13577-026-01363-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,9]]},"references-count":32,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2026,3]]}},"alternative-id":["1363"],"URL":"https:\/\/doi.org\/10.1007\/s13577-026-01363-7","relation":{},"ISSN":["1749-0774"],"issn-type":[{"value":"1749-0774","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,9]]},"assertion":[{"value":"21 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they do not have conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The ethics committee of the National Cancer Center (Tokyo, Japan) approved the use of clinical materials for this study (approval number 2004\u2013050).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}],"article-number":"51"}}